Biodistribution of nonviral cationic vector/DNA complexes was studied after systemic or intratracheal administration to the lungs and correlated with transgene expression. Intravenous injection in ...

Backed by NIH, DNA Nanobots aims to disrupt gene therapy with scalable, non-viral platform—$5M round now open to select investors. We're at a pivotal moment, with platform validation and NIH support, ...

The global DNA vaccine market valued at USD 590 million in 2025, it is projected to reach nearly USD 1041.68 million by 2034, ...

HAMPTON, England--(BUSINESS WIRE)--Touchlight, a CDMO enabling the development of genetic medicines with its enzymatic doggybone DNA (dbDNA) technology, today announced that the Company has used its ...

The new administration has a different perspective of vaccines than the previous administration, causing confusion with the ...

The plasmid DNA manufacturing market offers significant opportunities due to the outsourcing trend and rising demand in ...

Many biotech and pharmaceutical companies focused on mRNA manufacturing experience challenges associated with their plasmid DNA (pDNA) supply, including slow or delayed production and poor or ...

HAMPTON, England--(BUSINESS WIRE)--Touchlight, a company pioneering enzymatic DNA production, a critical material in many new genetic medicine treatments, has completed the redevelopment and expansion ...